Key points from article :
Researchers found a new way to combat age-related macular degeneration (AMD), the leading cause of vision loss in older adults.
Boosting a protein called IRAK-M protects retinal cells from degeneration.
This method treats AMD regardless of the specific underlying cause.
It could be more effective than current AMD treatments that target specific pathways.
The discovery paves the way for early AMD detection and improved therapies.
Cirrus Therapeutics, a new company spun out of University of Bristol, is developing therapies based on this research.
Researchers by the University of Bristol, published in Science Translational Medicine.
